936
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Maternal plasma visfatin in preterm labor

, , MD, , , , , , , , , & show all
Pages 693-704 | Received 24 Feb 2009, Accepted 11 Mar 2009, Published online: 19 Aug 2009

References

  • Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol 1983; 62: 137–144
  • Romero R, Mazor M, Wu Y K, Sirtori M, Oyarzun E, Mitchell M D, Hobbins J C. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12: 262–279
  • Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988; 31: 553–584
  • Romero R, Brody D T, Oyarzun E, Mazor M, Wu Y K, Hobbins J C, Durum S K. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160: 1117–1123
  • Romero R, Manogue K R, Mitchell M D, Wu Y K, Oyarzun E, Hobbins J C, Cerami A. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989; 161: 336–341
  • Ledger W J. Infection and premature labor. Am J Perinatol 1989; 6: 234–236
  • Gibbs R S, Romero R, Hillier S L, Eschenbach D A, Sweet R L. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166: 1515–1528
  • Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa J E, Rojas I. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995; 22: 281–342
  • Brocklehurst P. Infection and preterm delivery. BMJ 1999; 318: 548–549
  • Romero R, Espinoza J, Mazor M, Chaiworapongsa T. The preterm parturition syndrome. 2004; 28–60
  • Romero R, Espinoza J, Kusanovic J P, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006; 113(Suppl 3)17–42
  • Mazaki-Tovi S, Romero R, Kusanovic J P, Erez O, Pineles B L, Gotsch F, Mittal P, Than N G, Espinoza J, Hassan S S. Recurrent preterm birth. Semin Perinatol 2007; 31: 142–158
  • Gotsch F, Romero R, Kusanovic J P, Mazaki-Tovi S, Pineles B L, Erez O, Espinoza J, Hassan S S. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007; 50: 652–683
  • Romero R, Nien J K, Espinoza J, Todem D, Fu W, Chung H, Kusanovic J P, Gotsch F, Erez O, Mazaki-Tovi S, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9–23
  • Hirsch E, Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 2005; 12: 145–155
  • Cassell G H, Davis R O, Waites K B, Brown M B, Marriott P A, Stagno S, Davis J K. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983; 10: 294–302
  • Romero R, Kadar N, Hobbins J C, Duff G W. Infection and labor: the detection of endotoxin in amniotic fluid. Am J Obstet Gynecol 1987; 157: 815–819
  • Romero R, Quintero R, Oyarzun E, Wu Y K, Sabo V, Mazor M, Hobbins J C. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988; 159: 661–666
  • Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis A P, Hobbins J C. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161: 817–824
  • Romero R, Shamma F, Avila C, Jimenez C, Callahan R, Nores J, Mazor M, Brekus C A, Hobbins J C. Infection and labor. VI. Prevalence, microbiology, and clinical significance of intraamniotic infection in twin gestations with preterm labor. Am J Obstet Gynecol 1990; 163: 757–761
  • Romero R, Avila C, Brekus C A, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann NY Acad Sci 1991; 622: 355–375
  • Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165: 813–820
  • Gray D J, Robinson H B, Malone J, Thomson R B, Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992; 12: 111–117
  • Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, Mazor M, Treadwell M C, Cotton D B. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992; 167: 1086–1091
  • McDuffie R S, Jr, Sherman M P, Gibbs R S. Amniotic fluid tumor necrosis factor-alpha and interleukin-1 in a rabbit model of bacterially induced preterm pregnancy loss. Am J Obstet Gynecol 1992; 167: 1583–1588
  • Romero R, Mazor M, Morrotti R, Avila C, Oyarzun E, Insunza A, Parra M, Behnke E, Montiel F, Cassell G H. Infection and labor. VII. Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term. Am J Obstet Gynecol 1992; 166: 129–133
  • Romero R, Salafia C M, Athanassiadis A P, Hanaoka S, Mazor M, Sepulveda W, Bracken M B. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol 1992; 166: 1382–1388
  • Watts D H, Krohn M A, Hillier S L, Eschenbach D A. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992; 79: 351–357
  • Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993; 5: 81–88
  • Gomez R, Romero R, Galasso M, Behnke E, Insunza A, Cotton D B. The value of amniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994; 32: 200–210
  • Gravett M G, Witkin S S, Haluska G J, Edwards J L, Cook M J, Novy M J. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171: 1660–1667
  • Andrews W W, Hauth J C, Goldenberg R L, Gomez R, Romero R, Cassell G H. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995; 173: 606–612
  • Hirsch E, Saotome I, Hirsh D. A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995; 172: 1598–1603
  • Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995; 40: 375–379
  • Mazor M, Hershkovitz R, Ghezzi F, Maymon E, Horowitz S, Leiberman J R. Intraamniotic infection in patients with preterm labor and twin pregnancies. Acta Obstet Gynecol Scand 1996; 75: 624–627
  • Romero R, Gomez R, Mazor M, Ghezzi F, Yoon B H. The preterm labor syndrome. 1997; 29–49
  • Yoon B H, Romero R, Jun J K, Park K H, Park J D, Ghezzi F, Kim B I. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825–830
  • Romero R, Gomez R, Ghezzi F, Yoon B H, Mazor M, Edwin S S, Berry S M. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179: 186–193
  • Ghezzi F, Gomez R, Romero R, Yoon B H, Edwin S S, David C, Janisse J, Mazor M. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998; 78: 5–10
  • Gomez R, Romero R, Ghezzi F, Yoon B H, Mazor M, Berry S M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194–202
  • Yoon B H, Romero R, Kim M, Kim E C, Kim T, Park J S, Jun J K. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000; 183: 1130–1137
  • Romero R, Maymon E, Pacora P, Gomez R, Mazor M, Yoon B H, Berry S M. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha. Am J Obstet Gynecol 2000; 183: 1070–1077
  • Pacora P, Romero R, Maymon E, Gervasi M T, Gomez R, Edwin S S, Yoon B H. Participation of the novel cytokine interleukin 18 in the host response to intra-amniotic infection. Am J Obstet Gynecol 2000; 183: 1138–1143
  • Challis J R, Lye S J, Gibb W, Whittle W, Patel F, Alfaidy N. Understanding preterm labor. Ann NY Acad Sci 2001; 943: 225–234
  • Yoon B H, Oh S Y, Romero R, Shim S S, Han S Y, Park J S, Jun J K. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001; 185: 1162–1167
  • Gibbs R S, Davies J K, McDuffie R S, Jr, Leslie K K, Sherman M P, Centretto C A, Wolf D M. Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy. Am J Obstet Gynecol 2002; 186: 234–239
  • Goldenberg R L, Andrews W W, Hauth J C. Choriodecidual infection and preterm birth. Nutr Rev 2002; 60: S19–S25
  • Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infection and prematurity and the role of preventive strategies. Semin Neonatol 2002; 7: 259–274
  • Yoon B H, Romero R, Lim J H, Shim S S, Hong J S, Shim J Y, Jun J K. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003; 189: 919–924
  • Elovitz M A, Mrinalini C. Animal models of preterm birth. Trends Endocrinol Metab 2004; 15: 479–487
  • Keelan J A, Yang J, Romero R J, Chaiworapongsa T, Marvin K W, Sato T A, Mitchell M D. Epithelial cell-derived neutrophil-activating peptide-78 is present in fetal membranes and amniotic fluid at increased concentrations with intra-amniotic infection and preterm delivery. Biology of Reproduction 2004; 70: 253–259
  • Menon R, Fortunato S J. Fetal membrane inflammatory cytokines: a switching mechanism between the preterm premature rupture of the membranes and preterm labor pathways. J Perinat Med 2004; 32: 391–399
  • Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization?. Fertil Steril 2004; 82: 799–804
  • Chaiworapongsa T, Romero R, Espinoza J, Kim Y M, Edwin S, Bujold E, Gomez R, Kuivaniemi H. Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2005; 18: 405–416
  • Esplin M S, Romero R, Chaiworapongsa T, Kim Y M, Edwin S, Gomez R, Mazor M, Adashi E Y. Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection. J Matern Fetal Neonatal Med 2005; 17: 365–373
  • Vogel I, Thorsen P, Curry A, Sandager P, Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand 2005; 84: 516–525
  • Mazaki-Tovi S, Romero R, Kusanovic J P, Erez O, Gotsch F, Mittal P, Than N G, Nhan-Chang C L, Hamill N, Vaisbuch E, et al. Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition. J Perinat Med 2008; 36: 485–496
  • Kusanovic J P, Romero R, Mazaki-Tovi S, Chaiworapongsa T, Mittal P, Gotsch F, Erez O, Vaisbuch E, Edwin S, Than N G, et al. Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Medi 2008; 21: 902–916
  • Fidel P L, Jr, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, Cotton D B. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170: 1467–1475
  • Kaga N, Katsuki Y, Obata M, Shibutani Y. Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol 1996; 174: 754–759
  • Romero R, Mazor M, Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991; 165: 969–971
  • Romero R, Tartakovsky B. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am J Obstet Gynecol 1992; 167: 1041–1045
  • Gilles H M, Lawson J B, Sibelas M, Voller A, Allan N. Malaria, anaemia and pregnancy. Ann Trop Med Parasitol 1969; 63: 245–263
  • Herd N, Jordan T. An investigtion of malaria during pregnancy in Zimbabwe. Afr J Med 1981; 27: 62
  • Kalanda B F, Verhoeff F H, Chimsuku L, Harper G, Brabin B J. Adverse birth outcomes in a malarious area. Epidemiol Infect 2006; 134: 659–666
  • Hibbard L, Thrupp L, Summeril S, Smale M, Adams R. Treatment of pyelonephritis in pregnancy. Am J Obstet Gynecol 1967; 98: 609–615
  • Patrick M J. Influence of maternal renal infection on the foetus and infant. Arch Dis Child 1967; 42: 208–213
  • Wren B G. Subclinical renal infection and prematurity. Med J Aust 1969; 2: 596–600
  • Cunningham F G, Morris G B, Mickal A. Acute pyelonephritis of pregnancy: A clinical review. Obstet Gynecol 1973; 42: 112–117
  • Kaul A K, Khan S, Martens M G, Crosson J T, Lupo V R, Kaul R. Experimental gestational pyelonephritis induces preterm births and low birth weights in C3H/HeJ mice. Infect Immun 1999; 67: 5958–5966
  • Benedetti T J, Valle R, Ledger W J. Antepartum pneumonia in pregnancy. Am J Obstet Gynecol 1982; 144: 413–417
  • Madinger N E, Greenspoon J S, Ellrodt A G. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?. Am J Obstet Gynecol 1989; 161: 657–662
  • Munn M B, Groome L J, Atterbury J L, Baker S L, Hoff C. Pneumonia as a complication of pregnancy. J Matern Fetal Med 1999; 8: 151–154
  • Offenbacher S, Beck J D, Lieff S, Slade G. Role of periodontitis in systemic health: spontaneous preterm birth. J Den Ed 1998; 62: 852–858
  • Madianos P N, Lieff S, Murtha A P, Boggess K A, Auten R L, Jr, Beck J D, Offenbacher S. Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure. Ann Periodontol 2001; 6: 175–182
  • Jeffcoat M K, Geurs N C, Reddy M S, Goldenberg R L, Hauth J C. Current evidence regarding periodontal disease as a risk factor in preterm birth. Ann Periodontol 2001; 6: 183–188
  • Offenbacher S, Lieff S, Boggess K A, Murtha A P, Madianos P N, Champagne C M, McKaig R G, Jared H L, Mauriello S M, Auten, et al. Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001; 6: 164–174
  • Jeffcoat M K, Geurs N C, Reddy M S, Cliver S P, Goldenberg R L, Hauth J C. Periodontal infection and preterm birth: results of a prospective study. J Am Den Assoc 2001; 132: 875–880
  • Goepfert A R, Jeffcoat M K, Andrews W W, Fay -, tersen O, Cliver S P, Goldenberg R L, Hauth J C. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol 2004; 104: 777–783
  • Jarjoura K, Devine P C, Perez-Delboy A, Herrera-Abreu M, D'Alton M, Papapanou P N. Markers of periodontal infection and preterm birth. Am J Obstet Gynecol 2005; 192: 513–519
  • Khader Y S, Ta'ani Q. Periodontal diseases and the risk of preterm birth and low birth weight: A meta-analysis. J of Periodontol 2005; 76: 161–165
  • Offenbacher S, Boggess K A, Murtha A P, Jared H L, Lieff S, McKaig R G, Mauriello S M, Moss K L, Beck J D. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol 2006; 107: 29–36
  • Xiong X, Buekens P, Fraser W D, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG 2006; 113: 135–143
  • Johnson M J, Petri M, Witter F R, Repke J T. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 1995; 86: 396–399
  • Le H D, Wechsler B, Vauthier-Brouzes D, Seebacher J, Lefebvre G, Bletry O, Darbois Y, Godeau P, Piette J C. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 1997; 36: 772–777
  • Dominitz J A, Young J C, Boyko E J. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97: 641–648
  • Norgard B, Fonager K, Pedersen L, Jacobsen B A, Sorensen H T. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003; 52: 243–247
  • Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy–a population based study. Eur J Epidemiol 2000; 16: 167–171
  • Dombrowski M P, Schatz M, Wise R, Momirova V, Landon M, Mabie W, Newman R B, McNellis D, Hauth J C, Lindheimer M, et al. Asthma during pregnancy. Obstet Gynecol 2004; 103: 5–12
  • Adams M M, Sarno A P, Harlass F E, Rawlings J S, Read J A. Risk factors for preterm delivery in a healthy cohort. Epidemiology 1995; 6: 525–532
  • Nohr E A, Bech B H, Vaeth M, Rasmussen K M, Henriksen T B, Olsen J. Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2007; 21: 5–14
  • Bhattacharya S, Campbell D M, Liston W A, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health 2007; 7: 168
  • Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann NY Acad Sci 1999; 892: 146–154
  • Kahn S E, Hull R L, Utzschneider K M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840–846
  • Tilg H, Moschen A R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772–783
  • Catalano P M, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-De M S. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006; 49: 1677–1685
  • Gurkan F, Atamer Y, Ece A, Kocyigit Y, Tuzun H, Mete N. Serum leptin levels in asthmatic children treated with an inhaled corticosteroid. Ann Allergy Asthma Immunol 2004; 93: 277–280
  • Guler N, Kirerleri E, Ones U, Tamay Z, Salmayenli N, Darendeliler F. Leptin: does it have any role in childhood asthma?. J Allergy Clin Immunol 2004; 114: 254–259
  • Barbier M, Vidal H, Desreumaux P, Dubuquoy L, Bourreille A, Colombel J F, Cherbut C, Galmiche J P. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003; 27: 987–991
  • Tuzun A, Uygun A, Yesilova Z, Ozel A M, Erdil A, Yaman H, Bagci S, Gulsen M, Karaeren N, Dagalp K. Leptin levels in the acute stage of ulcerative colitis. J Gastroenterol Hepatol 2004; 19: 429–432
  • Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J, Muller-Ladner U, Gay S. Adipocytokines in synovial fluid. JAMA 2003; 290: 1709–1710
  • Bernotiene E, Palmer G, Talabot-Ayer D, Szalay-Quinodoz I, Aubert M L, Gabay C. Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice. Arthritis Res Ther 2004; 6: R256–R263
  • Matarese G, Sanna V, Di G A, Lord G M, Howard J K, Bloom S R, Lechler R I, Fontana S, Zappacosta S. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol 2001; 31: 1324–1332
  • Batocchi A P, Rotondi M, Caggiula M, Frisullo G, Odoardi F, Nociti V, Carella C, Tonali P A, Mirabella M. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol 2003; 139: 150–154
  • Ahima R S, Flier J S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327–332
  • Yang W S, Lee W J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C L, Chen C L, Tai T Y, Chuang L M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815–3819
  • Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799–1804
  • Nien J K, Mazaki-Tovi S, Romero R, Erez O, Kusanovic J P, Gotsch F, Pineles B L, Gomez R, Edwin S, Mazor M, et al. Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. J Perinat Med 2007; 35: 522–531
  • Klok M D, Jakobsdottir S, Drent M L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21–34
  • Nien J K, Mazaki-Tovi S, Romero R, Kusanovic J P, Erez O, Gotsch F, Pineles B L, Friel L A, Espinoza J, Goncalves L, et al. Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med 2007; 35: 513–521
  • Nien J K, Mazaki-Tovi S, Romero R, Erez O, Kusanovic J P, Gotsch F, Pineles B L, Gomez R, Edwin S, Mazor M, et al. Adiponectin in severe preeclampsia. J Perinat Med 2007; 35: 503–512
  • Mazaki-Tovi S, Romero R, Kusanovic J P, Erez O, Vaisbuch E, Gotsch F, Mittal P, Than G N, Nhan-Chang C, Chaiworapongsa T, et al. Adiponectin multimers in maternal plasma. J Matern Fetal Neonatal Med 2008; 21: 796–815
  • Mazaki-Tovi S, Romero R, Kusanovic J P, Vaisbuch E, Erez O, Than G N, Chaiworapongsa T, Nhan-Chang C, Pacora P, Gotsch F, et al. Maternal visfatin concentration in normal pregnancy. J Perinat Med 2009; 37: 206–217
  • Mazaki-Tovi S, Romero R, Kusanovic J P, Vaisbuch E, Erez O, Than G N, Chaiworapongsa T, Nhan-Chang C, Pacora P, Gotsch F, et al. Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight. J Perinat Med 2009; 37: 218–231
  • Verma S, Li S H, Wang C H, Fedak P W, Li R K, Weisel R D, Mickle D A. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736–740
  • Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789–5795
  • Jia S H, Li Y, Parodo J, Kapus A, Fan L, Rotstein O D, Marshall J C. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 1318–1327
  • Ognjanovic S, Bryant-Greenwood G D. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002; 187: 1051–1058
  • Gainsford T, Willson T A, Metcalf D, Handman E, McFarlane C, Ng A, Nicola N A, Alexander W S, Hilton D J. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 1996; 93: 14564–14568
  • Matarese G, Moschos S, Mantzoros C S. Leptin in immunology. J Immunol 2005; 174: 3137–3142
  • Tian Z, Sun R, Wei H, Gao B. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 2002; 298: 297–302
  • Lord G M, Matarese G, Howard J K, Baker R J, Bloom S R, Lechler R I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897–901
  • Wolf A M, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323: 630–635
  • Yamaguchi N, Argueta J G, Masuhiro Y, Kagishita M, Nonaka K, Saito T, Hanazawa S, Yamashita Y. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 2005; 579: 6821–6826
  • Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner A J, Tomiyama Y, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723–1732
  • Okamoto Y, Folco E J, Minami M, Wara A K, Feinberg M W, Sukhova G K, Colvin R A, Kihara S, Funahashi T, Luster A D, et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res 2008; 102: 218–225
  • Mazaki-Tovi S, Romero R, Kusanovic J P, Erez O, Vaisbuch E, Gotsch F, Mittal P, Than N G, Nhan-Chang C L, Chaiworapongsa T, et al. Maternal serum adiponectin multimers in preeclampsia. J Perinat Med 2009, In Press
  • Mazaki-Tovi S, Kanety H, Sivan E. Adiponectin and human pregnancy. Curr Diab Rep 2005; 5: 278–281
  • Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Schiff E, Sivan E. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol 2005; 193: 1238–1242
  • Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Wiser A, Schiff E, Sivan E. Maternal serum adiponectin levels during human pregnancy. J Perinatol 2007; 27: 77–81
  • Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Efraty Y, Schiff E, Shoham A, Sivan E. Determining the source of fetal adiponectin. J Reprod Med 2007; 52: 774–778
  • Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Yinon Y, Wiser A, Schiff E, Sivan E. Adiponectin and leptin concentrations in dichorionic twins with discordant and concordant growth. J Clin Endocrinol Metab 2009; 94: 892–8
  • Mazaki-Tovi S, Romero R, Kusanovic J P, Vaisbuch E, Erez O, Than N G, Chaiworapongsa T, Nhan-Chang C L, Pacora P, Gotsch F, et al. Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight. J Perinat Med 2009; 37: 218–231
  • Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R, Kanety H. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003; 88: 5656–5660
  • Marvin K W, Keelan J A, Eykholt R L, Sato T A, Mitchell M D. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm. Mol Hum Reprod 2002; 8: 399–408
  • Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14: 1431–1437
  • Ye S Q, Simon B A, Maloney J P, Zambelli-Weiner A, Gao L, Grant A, Easley R B, McVerry B J, Tuder R M, Standiford T, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005; 171: 361–370
  • Hug C, Lodish H F. MedicineVisfatin: a new adipokine. Science 2005; 307: 366–367
  • Sethi J K, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes?. Trends Mol Med 2005; 11: 344–347
  • Tanaka M, Nozaki M, Fukuhara A, Segawa K, Aoki N, Matsuda M, Komuro R, Shimomura I. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun 2007; 359: 194–201
  • Xie H, Tang S Y, Luo X H, Huang J, Cui R R, Yuan L Q, Zhou H D, Wu X P, Liao E Y. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007; 80: 201–210
  • Ye S Q, Zhang L Q, Adyshev D, Usatyuk P V, Garcia A N, Lavoie T L, Verin A D, Natarajan V, Garcia J G. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res 2005; 70: 142–151
  • Bajwa E K, Yu C L, Gong M N, Thompson B T, Christiani D C. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med 2007; 35: 1290–1295
  • Carpenter M W, Coustan D R. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768–773
  • ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001; 98: 525–538
  • Alexander G R, Himes J H, Kaufman R B, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87: 163–168
  • Gonzalez R P, Gomez R M, Castro R S, Nien J K, Merino P O, Etchegaray A B, Carstens M R, Medina L H, Viviani P G, Rojas I T. [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. Rev Med Chil 2004; 132: 1155–1165
  • Yoon B H, Romero R, Moon J B, Shim S S, Kim M, Kim G, Jun J K. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185: 1130–1136
  • Romero R, Emamian M, Quintero R, Wan M, Hobbins J C, Mazor M, Edberg S. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol 1988; 159: 114–119
  • Romero R, Jimenez C, Lohda A K, Nores J, Hanaoka S, Avila C, Callahan R, Mazor M, Hobbins J C, Diamond M P. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990; 163: 968–974
  • Romero R, Quintero R, Nores J, Avila C, Mazor M, Hanaoka S, Hagay Z, Merchant L, Hobbins J C. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991; 165: 821–830
  • Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon M R, Stumvoll M, Bluher M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005; 54: 2911–2916
  • Choi K C, Ryu O H, Lee K W, Kim H Y, Seo J A, Kim S G, Kim N H, Choi D S, Baik S H, Choi K M. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res Commun 2005; 336: 747–753
  • Frydelund-Larsen L, Akerstrom T, Nielsen S, Keller P, Keller C, Pedersen B K. Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. Am J Physiol Endocrinol Metab 2007; 292: E24–E31
  • Hammarstedt A, Pihlajamaki J, Rotter S V, Gogg S, Jansson P A, Laakso M, Smith U. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 2006; 91: 1181–1184
  • Sethi J K. Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?. Curr Hypertens Rep 2007; 9: 33–38
  • Tanaka M, Nozaki M, Fukuhara A, Segawa K, Aoki N, Matsuda M, Komuro R, Shimomura I. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun 2007; 359: 194–201
  • Marvin K W, Keelan J A, Eykholt R L, Sato T A, Mitchell M D. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm. Mol Hum Reprod 2002; 8: 399–408
  • Nemeth E, Tashima L S, Yu Z, Bryant-Greenwood G D. Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells. Am J Obstet Gynecol 2000; 182: 50–59
  • Nemeth E, Millar L K, Bryant-Greenwood G. Fetal membrane distention: II. Differentially expressed genes regulated by acute distention in vitro. Am J Obstet Gynecol 2000; 182: 60–67
  • Kendal-Wright C E, Hubbard D, Bryant-Greenwood G D. Chronic stretching of amniotic epithelial cells increases pre-B Cell colony-enhancing factor (PBEF/Visfatin) expression and protects them from apoptosis. Placenta 2008; 29: 255–265
  • Ognjanovic S, Bao S, Yamamoto S Y, Garibay-Tupas J, Samal B, Bryant-Greenwood G D. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001; 26: 107–117
  • Ognjanovic S, Tashima L S, Bryant-Greenwood G D. The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis. Am J Obstet Gynecol 2003; 189: 1187–1195
  • Ognjanovic S, Ku T L, Bryant-Greenwood G D. Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium. Am J Obstet Gynecol 2005; 193: 273–282
  • Esplin M S, Fausett M B, Peltier M R, Hamblin S, Silver R M, Branch D W, Adashi E Y, Whiting D. The use of cDNA microarray to identify differentially expressed labor-associated genes within the human myometrium during labor. Am J Obstet Gynecol 2005; 193: 404–413
  • Dahl T B, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A, Damas J K, Tunheim S H, Ueland T, Smith C, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007; 115: 972–980
  • Moschen A R, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178: 1748–1758
  • Jia S H, Li Y, Parodo J, Kapus A, Fan L, Rotstein O D, Marshall J C. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 1318–1327
  • Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino J J, Gualillo O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1198–1201
  • Haider D G, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49: 1909–1914
  • Haider D G, Holzer G, Schaller G, Weghuber D, Widhalm K, Wagner O, Kapiotis S, Wolzt M. The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr 2006; 43: 548–549
  • Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, Kocelak P, Semik-Grabarczyk E, Holecki M, Dabrowski P, Skorupa A. Serum concentration of visfatin in obese women. Metabolism 2007; 56: 1131–1134
  • Filippatos T D, Derdemezis C S, Kiortsis D N, Tselepis A D, Elisaf M S. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. J Endocrinol Invest 2007; 30: 323–326
  • Filippatos T D, Derdemezis C S, Gazi I F, Lagos K, Kiortsis D N, Tselepis A D, Elisaf M S. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest 2008; 38: 71–72
  • Sandeep S, Velmurugan K, Deepa R, Mohan V. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism 2007; 56: 565–570
  • Chen M P, Chung F M, Chang D M, Tsai J C, Huang H F, Shin S J, Lee Y J. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91: 295–299
  • Fernandez-Real J M, Moreno J M, Chico B, Lopez-Bermejo A, Ricart W. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 2007; 30: 616–621
  • Lopez-Bermejo A, Chico-Julia B, Fernandez-Balsells M, Recasens M, Esteve E, Casamitjana R, Ricart W, Fernandez-Real J M. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006; 55: 2871–2875
  • Filippatos T D, Derdemezis C S, Kiortsis D N, Tselepis A D, Elisaf M S. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. J Endocrinol Invest 2007; 30: 323–326
  • Filippatos T D, Derdemezis C S, Gazi I F, Lagos K, Kiortsis D N, Tselepis A D, Elisaf M S. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest 2008; 38: 71–72
  • Mastorakos G, Valsamakis G, Papatheodorou D C, Barlas I, Margeli A, Boutsiadis A, Kouskouni E, Vitoratos N, Papadimitriou A, Papassotiriou I, et al. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem 2007; 53: 1477–1483
  • Morgan S A, Bringolf J B, Seidel E R. Visfatin expression is elevated in normal human pregnancy. Peptides 2008; 29: 1382–1389
  • Katwa L C, Seidel E R. Visfatin in pregnancy: proposed mechanism of peptide delivery. Amino Acids 2008, DOI 10.1007
  • Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006; 110: 605–609
  • Lewandowski K C, Stojanovic N, Press M, Tuck S M, Szosland K, Bienkiewicz M, Vatish M, Lewinski A, Prelevic G M, Randeva H S. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007; 50: 1033–1037
  • Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, et al. Serum levels of the adipokine visfatin are increased in preeclampsia. Clin Endocrinol (Oxf) 2008; 69: 69–73
  • Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf) 2007; 66: 434–439
  • Kendal-Wright C E. Stretching, mechanotransduction, and proinflammatory cytokines in the fetal membranes. Reprod Sci 2007; 14: 35–41
  • Kendal C E, Bryant-Greenwood G D. Pre-B-cell colony-enhancing factor (PBEF/Visfatin) gene expression is modulated by NF-kappaB and AP-1 in human amniotic epithelial cells. Placenta 2007; 28: 305–314
  • Luk T, Malam Z, Marshall J C. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008; 83: 804–816
  • Taneja R, Parodo J, Jia S H, Kapus A, Rotstein O D, Marshall J C. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med 2004; 32: 1460–1469
  • Bajwa E K, Yu C L, Gong M N, Thompson B T, Christiani D C. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med 2007; 35: 1290–1295
  • Kashyap M L, Sivasamboo R, Sothy S P, Cheah J S, Gartside P S. Carbohydrate and lipid metabolism during human labor: free fatty acids, glucose, insulin, and lactic acid metabolism during normal and oxytocin-induced labor for postmaturity. Metabolism 1976; 25: 865–875
  • Katz M, Kroll D, Shapiro Y, Cristal N, Meizner I. Energy expenditure in normal labor. Isr J Med Sci 1990; 26: 254–257
  • Whaley W H, Zuspan F P, Nelson G H, Ahlquist R P. Alterations of plasma free fatty acids and glucose during labor. Am J Obstet Gynecol 1967; 97: 875–880
  • Felig P, Lynch V. [Starvation in human pregnancy: hypoglycemia, hypoinsulinemia, and hyperketonemia.]. Science 1970; 170: 990–992
  • Maheux P C, Bonin B, Dizazo A, Guimond P, Monier D, Bourque J, Chiasson J L. Glucose homeostasis during spontaneous labor in normal human pregnancy. J Clin Endocrinol Metab 1996; 81: 209–215
  • Goldstein S A, Elwyn D H. The effects of injury and sepsis on fuel utilization. Annu Rev Nutr 1989; 9: 445–473
  • Tappy L, Chiolero R. Substrate utilization in sepsis and multiple organ failure. Crit Care Med 2007; 35: S531–S534
  • Trager K, DeBacker D, Radermacher P. Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Curr Opin Crit Care 2003; 9: 271–278
  • Iqbal J, Zaidi M. TNF regulates cellular NAD+ metabolism in primary macrophages. Biochem Biophys Res Commun 2006; 342: 1312–1318
  • Nowell M A, Richards P J, Fielding C A, Ognjanovic S, Topley N, Williams A S, Bryant-Greenwood G, Jones S A. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2006; 54: 2084–2095

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.